Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
RANI
#3481
Rani Therapeutics Holdings, Inc. Class A Common Stock
1.3
7
-0.72%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-0.72%
Variazione Mensile
-0.72%
Variazione di 6 mesi
+140.35%
Variazione Annuale
-8.67%
Chiusura Precedente
1.3
8
Open
1.3
7
Bid
Ask
Low
1.3
7
High
1.3
7
Volume
19
Mercati
Mercato Azionario Statunitense
Salute
RANI
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
24.39 M
25.3 M
26.04 M
33.51 M
—
Valuation ratios
Enterprise value
3.17 B
1.18 B
682.83 M
312.74 M
—
Price to earnings ratio
—
-4.61
-2.53
-1.3
-3.62
Price to sales ratio
—
—
—
0.04
—
Price to cash flow ratio
—
-3.02
-1.68
-1.1
-3.24
Price to book ratio
—
3.81
6.68
19.58
16.66
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.07
0.28
0.59
0.82
1.48
Return on equity %
0.07
0.41
1.34
8.59
5.1
Return on invested capital %
4 359.55
3 939.3
895.26
523.42
—
Gross margin %
100
—
—
100
—
Operating margin %
1 899.12
—
—
5 186.19
—
EBITDA margin %
—
—
—
—
—
Net margin %
306.62
—
—
2 920.04
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
45.3
20.96
6.36
1.5
3.17
Inventory turnover
—
—
—
—
—
Asset turnover
0.02
0
—
0.02
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0.27
0.42
0.26
0.64
Long term debt to total equity ratio
0
0.79
1.9
4.83
7.16
Per share metrics
Operating cash flow per share
—
1.95
2.01
1.25
0.81
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
5.27
0.23
0.13
0.8
Net current asset value per share
—
4.24
1.99
1.04
1.99
Tangible book value per share
—
1.55
0.5
0.07
0.48
Working capital per share
—
4.04
1.68
0.35
-0.29
Book value per share
—
1.55
0.5
0.07
0.48
Notizie
Rani Therapeutics promuove Alireza Javadi a direttore tecnico
Rani Therapeutics promotes Alireza Javadi to chief technical officer
Rani Therapeutics avvia trial di fase 1 per trattamento orale dell’obesità
Rani Therapeutics begins phase 1 trial of oral obesity treatment
Rani Therapeutics modifica lo statuto, riduce il potere di voto delle azioni di Classe B
Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement
Rani Therapeutics annuncia collaborazione da 1,085 miliardi di dollari con Chugai
Rani Therapeutics announces $1.085 billion Chugai collaboration
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%
Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27
Il direttore di Rani Therapeutics Imran Mir A acquista azioni per 1,26 milioni di dollari
Rani Therapeutics director Imran Mir a buys $1.26 million in stock